BTG USA licenses transvenous lead:
This article was originally published in Clinica
BTG USA says it has licensed a transvenous pacing lead to an unnamed cardiac company. The device, invented by Dr Leo Rubin of Suffern, New York, uses a helical wire to anchor the electrode near the His bundle. A second version uses retractable barbs. BTG USA, which is part of UK-based British Technology Group, acquired rights to the lead in 1992. It is patented in the US and the organisation is pursuing patent protection internationally. BTG would not name the purchaser but says it is a major supplier of cardiac care products.